Connection

MICHAEL LEWIS to Protein Tyrosine Phosphatase, Non-Receptor Type 12

This is a "connection" page, showing publications MICHAEL LEWIS has written about Protein Tyrosine Phosphatase, Non-Receptor Type 12.
  1. Combinatorial inhibition of PTPN12-regulated receptors leads to a broadly effective therapeutic strategy in triple-negative breast cancer. Nat Med. 2018 05; 24(4):505-511.
    View in: PubMed
    Score: 0.158
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.